The effect of amantadine hydrochloride (1-adamantanamine hydrochloride) on dengue virus replication was examined in vitro. Amantadine decreased the titers of all four types of dengue viruses grown in LLC-MK2 cells by greater than 90% at concentrations of 50 ,g/ml. There was no evidence for any cytopathic effect of the drug at concentrations less than 100 jg/ml. Studies of the time of addition showed that the antiviral effect was maximal when drug was added to virus cultures immediately after the viral adsorption period. In addition, amantadine caused a marked reduction in the growth of dengue virus type 2 in both human and rhesus peripheral blood leukocytes without affecting cell viability. These findings demonstrate that amantadine significantly inhibits the replication of dengue viruses in vitro and indicate a need to determine the efficacy of this drug against dengue virus infections in vivo.
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Dengue viruses are a major cause of morbidity and mortality among children in tropical Asia (5) . The dengue viruses constitute a subgroup of group B arboviruses (flaviviruses) and occur as four distinct antigenic types (14) . Humans infected with any of these serotypes exhibit symptoms ranging from relatively mild dengue fever to the more severe dengue hemorrhagic fever and life-threatening dengue shock syndrome (10) . The severe aspects of dengue virus disease have been associated with secondary heterologous dengue virus infections, suggesting that immunopathological processes play a significant role in both dengue hemorrhagic fever and dengue shock syndrome (6, 9) .
At the present time, an effective vaccine against dengue hemorrhagic fever is not avail able. Vaccine development in the dengue system is faced with theoretical difficulties, since a vaccine virus that induces only homotypic protection could itself sensitize and predispose an individual toward dengue hemorrhagic fever and dengue shock syndrome (23) . As a result, the need for effective control measures for dengue infections has stimulated a search for chemotherapeutic agents against this disease.
Amantadine hydrochloride (1-adamantanamine hydrochloride) has been reported to possess antiviral activity against a wide variety of viruses (15) . This present study examines the efficacy of amantadine against dengue virus infections and demonstrates that the drug significantly inhibits the replication of dengue viruses in vitro.
MATERIALS AND METHODS Virus and cell cultures. The following strains of dengue viruses recovered in BS-C-1 cells (African green monkey kidney cells) or in suckling mice from acute-phase sera from patients with dengue hemorrhagic fever in Thailand or the Philippines were chosen for study: dengue virus type 1 (strain 16007), type 2 (strain 16681), type 3 (strain 16562), and type 4 (strain H-241) (13, 14) . Viruses were propagated in rhesus monkey kidney cells (LLC-MK2) maintained with Eagle basal medium with Earles salts and 10% calf serum as previously described (11) . Briefly, 4 Infection of leukocytes. A 0.6-ml amount of the leukocyte suspension (107 cells per ml) was incubated with dengue virus type 2 (multiplicity of infection = 0.1 to 1.0) and anti-dengue type 4 serum (1:200 final dilution) in a total volume of 1 ml for 90 min at 370C. The inoculum was then washed off, and cells were resuspended at 2 x los/ml in RPMI 1640 supplemented with 2% fetal calf serum. Cultures (1 ml) were incubated at 370C in a 5% C02-in-air atmosphere for 3 to 5 days, then harvested and kept at -70°C for further use. Virus growth was assayed in LLC-MK2 cells as described above. Amantadine hydrochloride (lot no. 5042-175, E.I du Pont de Nemours, Newark, Del.) was added at the times indicated in figure legends.
Infection of LLC-MK2 celis. Cells were washed lx. with Hanks balanced salt solution and inoculated with dengue virus types 1 to 4 (multiplicity of infection = 0.01 to 0.1) for 90 min at 370C. The inoculum was poured off, and 5 ml of virus maintenance medium (Eagle basal medium supplemented with 2% calf serum) was added to each 1-ounce bottle. Aliquots of culture medium were removed daily and frozen at -70°C for future viral growth analysis. For drug studies, amantadine was dissolved in sterile distilled water and added at times indicated in the figure legends.
Viability studies. Viability of leukocytes was determined by trypan blue dye exclusion as previously described (18 Statistical analysis. Student's t test was used to evaluate the significance of observed differences between experimental and control groups. RESULTS Dose-response studies. Figure 1 shows the effect of increasing concentrations of amantadine on the growth of dengue virus type 2 in LLC-MK2 cells. At a concentration of 50 ug/mi, dengue virus titers were suppressed by more than 99% (P < 0.05). Amantadine did not cause any observable cytotoxic effects at this concentration. However, generalized rounding and destruction.of the cell sheet in both uninfected and dengue-infected LLC-MK2 monolayers were seen with amantadine concentrations equal to or greater than 100 pg/ml. Inhibition of dengue virus synthesis. (2, 7, 8, 19, 20, 21) . Table  3 tems indicated that the drug significantly reduced virus titers at concentrations of 25 ,ug/ml (data not shown). Viability studies, by trypan blue dye exclusion, demonstrated that amantadine did not decrease the viability of cultured PBL from either rhesus or human at concentrations less than 100 jig/ml.
DISCUSSION
The present studies demonstrate that amantadine hydrochloride significantly inhibits the replication of dengue viruses in vitro. With an LLC-MK2 tissue culture system, the growth of all four dengue virus types was markedly reduced at drug concentrations well below cytotoxic levels. Addition of the drug immediately after the 90-min viral adsorption period produced maximal inhibition of virus replication. Finally, in cultures of PBL from either rhesus or human donors, amantadine effectively reduced the growth of dengue virus type 2 without affecting cell viability.
Several lines of evidence support the hypothesis that mononuclear leukocytes play an integral role in the viral immunopathogenesis of dengue infections. Histopathological examination of patients dying of dengue f }morrhagic fever revealed marked depletion of iymphocytes in the thymic dependent areas of lymph nodes and spleen (1, 2) , and dengue viral antigens have been found on the surfaces of their mononuclear leukocytes (2) . Virus recovery studies on dengueinfected rhesus monkeys and human beings showed that dengue virus was associated in tissues rich in leukocytes (20, 21) . In addition, peripheral blood leukocytes from dengue-immune rhesus monkeys and humans supported dengue virus replication in vitro, whereas PBL cultures from nonimmune donors were not permissive (7, 8, 19) . VOL. 18, 1980 on August 27, 2017 by guest http://aac.asm.org/ Our findings demonstrated that amantadine significantly reduced the growth of dengue viruses in both rhesus and human PBL. Viability studies by trypan blue dye exclusion revealed no significant differences between drug-treated and untreated controls at concentrations of drug which inhibited virus replication. These viability data compared favorably with other previous reports examining the toxicity levels of amantadine and its analogs on PBL in vitro (18, 22) . Thus, amantadine is effective in limiting the growth of dengue viruses in the cells which appear to play a prominent role in the pathogenesis of dengue virus infections.
Although amantadine inhibits the replication of a wide variety of viruses in vitro, the exact mode of action of the drug has yet to be determined (15) . Most studies have concluded that the drug is not virucidal at concentrations active in tissue culture (16) and acts early in the virus replicative cycle either by blocking virus penetration into the host cell or suppressing the uncoating of the virus particle (4, 17) . Dose response studies have shown that amantadine causes gross cytopathic effects on a wide variety of cells at concentrations greatet than 100 ,ug/ml (15) . Similarly, in the dengue virus-LLC-MK2 system, 50 ,ug of amantadine per ml was well tolerated by the cells, and cytopathic effects were first observed at concentrations of 100 ,ug/ ml.
Time of addition studies have indicated that the effectiveness of amantadine is dependent on the specific virus-cell system used. With an influenza-chicken enbryo fibroblast system, amantadine did not reduce the growth of virus when added later than 30 min after the viral adsorption period (16) . However, studies with lymphocyte choriomeningitis virus in L-929 cells demonstrated that amantadine reduced virus titers when added as late as 20 h postinfection (24) . For dengue virus replication in vitro, it is now apparent that although the drug reduces virus replication when added 4 to 8 h postinfection, maximal inhibition occurs when the drug is present immediately after the viral adsorption period. Furthermore, unlike the influenza system where amantadine inhibits the replication of type A viruses but not type B viruses (15) , the growth of all 4 types of dengue viruses is reduced when cultured in the presence of amantadine.
Since severe dengue virus disease has been associated with secondary heterologous dengue virus infections (6, 9) , the development of an effective vaccine against dengue hemorrhagic fever has been hampered by the possibility of sensitizing individuals towards more severe dengue virus disease by injection with a homotypic virus vaccine (23) . As a result, other methods for controlling dengue virus infections are now being more closely examined. We are currently studying the efficacy of amantadine and its analogs against dengue virus infections in animal models.
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